Use of peroral form of vinorelbine in metastatic breast cancer – choice in favor of quality of life-Reference-Cited by-同舟云学术

Use of peroral form of vinorelbine in metastatic breast cancer – choice in favor of quality of life

Published:2022-07-26 Issue:13 Volume: Page:7-13
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Lubennikova E. V.¹^ORCID,Khoroshilov M. V.¹^ORCID,Drobot N. C.-D.¹^ORCID,Artamonova E. V.²^ORCID

Affiliation:

1. Russian Oncological Scientific Centre n. a. N. N. Blokhin

2. Russian Oncological Scientific Centre n. a. N. N. Blokhin; Russian National Research Medical University n. a. N. I. Pirogov; Moscow Regional Research Clinical Institute n. a. M. F. Vladimirsky

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference50 articles.

1. Slamon D.J., Leyland-Jones B., Shak S. et al Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001; 344: 783–792.

2. Swain S., Baselga J., Kim S. et al. Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer. N Engl J Med. 2015; 372: 724–734.

3. Diéras, V., Miles, D., Verma, S., Pegram, M., Welslau, M., Baselga, J., … & Gianni, L. (2017). Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of ﬁnal overall survival results from a randomised, open-label, phase 3 trial. The Lancet Oncology, 2018; 6: 732–742.

4. Weigel M.T., Ghazoui Z., Dunbier A. et al. Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer. Breast Cancer Research. 2012; 14 (3): P. 78.

5. Ross J.S., Slodkowska E.A., Symmans W.F. et al. The HER-2 receptor and breast cancer: ten years of ttargeted anti-HER-2 therapy and personalized medicine. Oncologist. 2009; 14 (4): 320–68.